TLR4 accelerates the progression of atherosclerosis and increases the expression of ICAM-1 and VCAM-1, leading to the synergistic activation of NF-κB in vascular walls in vivo and vascular smooth muscle cells in vitro (Shinohara et al., 2007). This evidence concerns the gene NFKB1 and atherosclerosis.